Investors

2015 Press Releases

Keyword Search
 
2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
May 07, 2015
Codexis Reports Financial Results for the First Quarter of 2015
-- Affirms 2015 financial guidance -- -- Conference call begins at 4:30 p.m. Eastern time today -- REDWOOD CITY, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces financial results for the quarter ended March 31, 2015. "We are continuing to make good progress financially and operationally as we drive toward profitability. During the first quarter, revenues in both our... 
May 05, 2015
Codexis to Present at May Investor Conferences
REDWOOD CITY, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that management will present at two investor conferences in May: Senior Vice President and CFO Gordon Sangster will present at the 16th Annual B. Riley & Company Investor Conference on Tuesday, May 12, 2015, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time). The conference is being held at the Loe... 
April 30, 2015
Codexis to Hold 2015 First Quarter Conference Call on May 7
REDWOOD CITY, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it will report first quarter 2015 financial results after market close on Thursday, May 7, 2015. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 Pacific Time) to discuss financial results and provide a company update. Live Call: ... 
March 03, 2015
Codexis Reports 2014 Fourth Quarter and Full Year Results
Achieves First Milestone Payment from GSK Introduces 2015 financial guidance -- Conference call begins at 4:30 p.m. Eastern time today -- REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, announces financial results for the fourth quarter and year ended December 31, 2014, and introduces financial guidance for 2015. "I'm proud to report a strong finish to a y... 
March 03, 2015
Codexis to Present at ROTH Conference
REDWOOD CITY, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster will present at the 27th Annual ROTH Conference on Tuesday, March 10, 2015, at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time). The conference is being held at the Ritz-Carlton Laguna Niguel in Dana Point, Calif. A live ... 
February 24, 2015
Codexis to Hold 2014 Fourth Quarter and Full Year Conference Call on March 3
REDWOOD CITY, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it will report fourth quarter and full year 2014 financial results after market close on Tuesday, March 3, 2015. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern Time (1:30 Pacific Time) to discuss financial results and provide a company update. ... 
February 02, 2015
Codexis to Present at BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that President and CEO John Nicols and Senior Vice President and CFO Gordon Sangster will present at the 17th Annual BIO CEO & Investor Conference on Monday, February 9, 2015, at 3:00 p.m. Eastern Time (12:00 p.m. Pacific Time). The conference is being held at the Waldorf Astoria in New York City. A li... 

Sign up for E-mail Alerts

You may automatically receive Codexis, Inc. information by e-mail




Enter your e-mail address here:
Print Page Print Page | E-mail Page E-mail Page |

Share Page

X
| Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSIS®

We are an industrial biotechnology company delivering real business results through biobased innovation in chemicals, fuels, pharmaceuticals, consumer, and industrial products.


PHARMACEUTICAL ENZYMES

Supporting faster, cleaner, more efficient pharmaceutical manufacturing processes

Codexis delivers a range of chemicals at kilogram to multi-ton scale, through a partnered manufacturing network

CODEXIS

WHAT WE DO


Codexis delivers revolutionary biocatalytic routes that no one else can


CODEXIS

MEDIA CENTER


Visit our Media Center for the latest product information, videos, imagery, technical papers and press information.


CAREERS AT CODEXIS

An opportunity to make a difference.

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information for the investment community


built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue